tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Recursion Pharmaceuticals Inc

RXRX
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
4.350USD
+0.300+7.41%
์ข…๊ฐ€ย 10-28 16:00๏ผˆET๏ผ‰
2.59B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
์žฅ์ „ ๊ฑฐ๋ž˜ย 06:21ย (ET)4.290USD-0.060-1.38%

Recursion Pharmaceuticals Inc

4.350
+0.300+7.41%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

RXRX ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Recursion Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ
์‹œ๊ฐ€์ด์•ก
2.59B
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-3.75
์ฃผ๋‹น์ˆœ์ด์ต
-1.16
์ˆ˜์ต
74.68M
์ˆœ์ด์ต
-463.66M
ROE
-57.16%
ROA
-42.33%
Recursion Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜
์ตœ์‹  ์ถœ์‹œ
Aug 5, 2026
EPS / ์˜ˆ์ƒ
-0.25/-0.23
์ˆ˜์ต / ์˜ˆ์ƒ
7.67M/11.95M

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
40.26%-0.25
55.84%-0.22
61.03%-0.21
-7.03%-0.36
-2.27%-0.41
-29.86%-0.50
-31.70%-0.53
22.46%-0.34
-3.17%-0.40
-13.56%-0.39
-30.45%-0.40
---0.44
---0.39
---0.34
---0.31
---1.06
----
----
----
----
์ˆ˜์ต
-60.10%7.67M
-56.11%6.47M
681.74%35.54M
-80.16%5.17M
33.34%19.22M
6.89%14.74M
-58.26%4.55M
147.62%26.08M
30.86%14.42M
13.68%13.79M
-20.36%10.89M
-19.96%10.53M
43.56%11.02M
127.53%12.13M
439.91%13.68M
419.34%13.16M
201.06%7.67M
108.16%5.33M
--2.53M
--2.53M
์ˆœ์ด์ต
23.79%-131.00M
41.97%-117.50M
39.56%-108.12M
-69.29%-162.25M
-76.23%-171.90M
-121.60%-202.49M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-61.75%-93.00M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
11.46%-57.49M
-27.45%-60.45M
-51.06%-65.56M
-82.24%-55.98M
---64.93M
---47.43M
์ˆœ์ด์ต๋ฅ 
-91.01%-1708.02%
-32.21%-1815.57%
92.27%-304.24%
-753.23%-3135.32%
-32.17%-894.23%
-107.31%-1373.26%
-360.89%-3935.46%
58.39%-367.46%
2.85%-676.56%
-23.04%-662.41%
-103.12%-853.88%
---883.10%
---696.43%
---538.38%
---420.39%
---695.47%
----
----
----
----
์ด ์ด์ต๋ฅ 
-920.94%-49.82%
-93.54%-92.99%
132.98%59.83%
-442.36%-183.81%
-113.48%-4.88%
-352.17%-48.04%
-2056.44%-181.43%
1743.89%53.69%
143.88%36.19%
836.22%19.05%
-55.28%9.27%
---3.27%
--14.84%
---2.59%
--20.74%
---43.06%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
-33.56%1.17%
-35.98%1.23%
-33.21%1.27%
-62.38%1.49%
-55.94%1.76%
850.16%1.92%
984.56%1.89%
1269.88%3.95%
1356.24%4.00%
-31.18%0.20%
93.55%0.17%
--0.29%
--0.27%
--0.29%
--0.09%
--0.11%
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
-60.10%7.67M
-56.11%6.47M
681.74%35.54M
-80.16%5.17M
33.34%19.22M
6.89%14.74M
-58.26%4.55M
147.62%26.08M
30.86%14.42M
13.68%13.79M
-20.36%10.89M
-19.96%10.53M
43.56%11.02M
127.53%12.13M
439.91%13.68M
419.34%13.16M
201.06%7.67M
108.16%5.33M
--2.53M
--2.53M
์˜์—… ์ด์ต
23.41%-134.97M
32.85%-128.50M
41.05%-108.33M
-75.08%-172.20M
-75.28%-176.23M
-98.64%-191.37M
-85.76%-183.77M
1.20%-98.35M
-23.04%-100.54M
-40.30%-96.34M
-62.23%-98.93M
-59.09%-99.55M
-28.91%-81.72M
-22.66%-68.67M
6.12%-60.98M
-34.85%-62.57M
-54.88%-63.39M
-83.64%-55.98M
---64.96M
---46.40M
์ˆœ์ด์ต
23.79%-131.00M
41.97%-117.50M
39.56%-108.12M
-69.29%-162.25M
-76.23%-171.90M
-121.60%-202.49M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-61.75%-93.00M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
11.46%-57.49M
-27.45%-60.45M
-51.06%-65.56M
-82.24%-55.98M
---64.93M
---47.43M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
2.78%603.46M
21.47%709.56M
13.80%812.85M
50.60%714.11M
12.40%587.16M
70.00%584.14M
63.02%714.27M
15.50%474.17M
21.20%522.38M
-30.18%343.62M
-23.11%438.14M
-14.76%410.52M
-21.06%431.02M
-20.56%492.13M
6.56%569.81M
-19.85%481.62M
-15.69%546.00M
179.26%619.46M
--534.72M
--600.87M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-26.91%119.89M
-8.65%129.70M
-21.21%147.71M
42.44%155.10M
90.54%164.03M
92.07%141.98M
101.21%187.47M
15.69%108.89M
-24.46%86.08M
-19.78%73.92M
-7.08%93.17M
13.35%94.12M
17.91%113.96M
7.52%92.15M
114.89%100.27M
93.36%83.04M
227.19%96.65M
219.15%85.70M
--46.66M
--42.94M
์ด ์ž์‚ฐ
-6.89%1.21B
2.63%1.34B
1.76%1.47B
92.64%1.40B
67.86%1.30B
133.98%1.31B
121.60%1.45B
15.17%726.50M
16.37%775.86M
-11.08%557.85M
-6.79%653.70M
3.15%630.83M
-0.86%666.70M
-14.56%627.37M
14.90%701.29M
-7.15%611.53M
-3.73%672.51M
170.03%734.32M
--610.35M
--658.61M
๋ถ€์ฑ„ ์ด๊ณ„
-22.32%297.67M
-15.23%314.75M
-17.05%343.26M
74.60%352.58M
100.20%383.21M
136.95%371.29M
117.50%413.82M
4.71%201.94M
-3.20%191.41M
-20.54%156.70M
-11.70%190.26M
-13.71%192.86M
-15.83%197.74M
-18.09%197.19M
219.67%215.48M
275.16%223.50M
320.46%234.94M
324.89%240.75M
--67.41M
--59.57M
์ž๋ณธ ์ด๊ณ„
-0.45%915.00M
9.72%1.02B
9.29%1.13B
99.59%1.05B
57.27%919.15M
132.82%933.95M
123.28%1.03B
19.77%524.56M
24.63%584.45M
-6.75%401.15M
-4.60%463.44M
12.87%437.97M
7.17%468.96M
-12.84%430.18M
-10.52%485.81M
-35.22%388.03M
-31.92%437.58M
129.27%493.57M
--542.94M
--599.03M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-38.64%-105.95M
38.54%-81.10M
60.09%-46.07M
-98.16%-117.36M
7.06%-76.42M
-28.99%-131.96M
-55.82%-115.43M
18.78%-59.23M
-21.87%-82.22M
-39.53%-102.30M
-65.54%-74.08M
-33.70%-72.92M
-9.48%-67.47M
-194.74%-73.32M
26.83%-44.75M
-65.04%-54.54M
-83.11%-61.62M
351.63%77.39M
---61.16M
---33.05M
์ˆœํˆฌ์ž
66.27%-1.96M
95.35%-338.00K
-100.45%-1.24M
44.13%-2.55M
-38.88%-5.81M
-9.27%-7.27M
11171.38%275.46M
-1214.70%-4.56M
-103.70%-4.18M
-24.59%-6.65M
68.82%-2.49M
-100.65%-347.00K
-141.56%-2.05M
-103.73%-5.34M
84.73%-7.98M
127.33%52.98M
179.52%4.94M
838.07%143.30M
---52.24M
---193.87M
์ˆœ์žฌ๋ฌดํ™œ๋™
-101.30%-1.27M
-108.56%-3.47M
1140.77%132.01M
1426.79%251.34M
-62.88%97.66M
191.62%40.53M
-86.81%10.64M
-69.38%16.46M
6848.03%263.12M
623.05%13.90M
-45.23%80.66M
2200.60%53.77M
41.94%3.79M
-7.77%1.92M
3779.24%147.26M
121.06%2.34M
-99.42%2.67M
-2.34%2.08M
--3.80M
---11.10M

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Recursion Pharmaceuticals Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 74.68M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 58.84M์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 812.85M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 13.80์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Recursion Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 1.47B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 1.76์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Recursion Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 343.26M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -17.05์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Recursion Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 1.13B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 9.29์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Recursion Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -648.13M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -35.31์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Recursion Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” -16.87M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -106.49์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Recursion Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 521.53M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 71.49์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -1.44์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 14.78์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -644.76M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -39.06์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -863.35์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -9.56์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 4.99์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -78.40์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 1.27์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -33.21์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -59.54์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 3.80์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -44.12์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -0.02์ž…๋‹ˆ๋‹ค.

Recursion Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Recursion Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -648.13M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -35.31์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ